Seroprevalence of chronic viral hepatitis markers in 791 recent immigrants in Catalonia, Spain. Screening and vaccination against hepatitis B recommendations;Seroprevalencia de marcadores de hepatitis crónica vírica en 791 inmigrantes recientes en Cataluña, España. Recomendaciones de cribado y de vacunación contra la hepatitis B

Revista Clinica Espanola

Volumn 208, Issue 9, 2008, Pages 426-431

  Valerio, Ll ^a,c   Barro, S ^a   Perez B ^a   Roca, C ^a   Fernandez J ^a   Solsona, L ^a   Aguilar, A ^a   Escriba J M ^b  

^a MEDICINA FAMILIAR Y COMUNITARIA   (Spain)

^b ICS   (Spain)

^c Unidad de Salud Internacional del Barcelonès Nord I Maresme   (Spain)

Author keywords

Hepatitis B; Hepatitis C; Immigrants; Prevalence; Spain

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; LAMIVUDINE; MARKER; MEMBRANE ANTIGEN;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CHRONIC HEPATITIS; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; ENDEMIC DISEASE; ETHICS; ETHNIC GROUP; EUROPEAN UNION; FEMALE; HEALTH CARE COST; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; SCREENING; SEROLOGY; SEROPREVALENCE; VACCINATION;

ADULT; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SPAIN; TRANSIENTS AND MIGRANTS;

EID: 60149108329     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1157/13127602     Document Type: Article

References (43)

1. Kretzschmar M, de Wit GA, Smits LJ, van der Laar MJ. Vaccination against hepatitis B in low endemic countries. Epidemiol Infect. 2002;128:229-44.
2. Bruguera M, Sánchez-Tapias JM. Viral hepatitis in immigrants and in adopted children. A problem of unknown magnitude in Spain. Med Clin (Barc). 2001;117:595-6.
3. Migrants Clinicians Network. Position paper. May 2005. Hepatitis screening, immunization and testing for mobile populations and immigrants from Mexico, Central and South America, and the Caribbean [consultado 02/05/2007]. Disponible en: www.migrantclinician.org/-resources/Hep-Position-Paper.pdf
4. Moreno D, Alegre F, García-González N. Virología, epidemiología y mecanismos de transmisión del VHB. An Sist San Nav. 2004;27:7-16.
5. Zarski JP. Epidemiology of chronic hepatitis B. Presse Med. 2006;35:304-7.
6. CAMFiC. Guia Clínica de Salut Internacional i immigració [consultado 02/05/2007]. Disponible en: http://www.camfic.org/grups-treball/ docs/cocoopsi/cocoopsi-guia-clinica-oficial%20(Inmigrants)%20def%20(24-7-06.pdf
7. López-Vélez R, Turrientes C, Gutiérrez C, Mateos M. Prevalence of hepatitis B, C and D markers in sub-saharian African immigrants. J Clin Gastroenterol. 1997;25:650-2.
8. Vall M, Arellano E, Armengol P, Escriba JM, Loureiro E, Saladie P, et al. Infección por el VIH y otras enfermedades de transmisión sexual entre inmigrantes en Barcelona (España). Enferm Infecc Micrbiol Clin. 2002;20:154-6.
9. Lacalle M, Gil G, Juberias G, Sagardui JK, González E, Martínez R, et al. Results of the application of a health test in a population of immigrants. Aten Primaria. 2000;25:634-8.
10. Roussos A, Goritsas C, Pappas T, Spanaki M, Papadaki P, Ferti A. Prevalence of hepatitis B and C markers among refugees in Athens. World J Gastroenterol. 2003;9:993-5.
11. Chiaramonte M, Pupo A, Menegon T, Baldo V; Malatesta R, Trivello R. HBV and HCV infection among non-European Union immigrants in North-East Italy. Epidemiol infect. 1998;121:179-83.
12. Chirstenson B, Bottiger M, Grillner L. The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect. 1997;119:221-5.
13. Plans-Rubio P. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain. Vaccine. 2004;22:4002-13.
14. Plans- Rubio P. Critical value of prevalence for vaccination programmes. The case of hepatitis A vaccination in Spain. Vaccine. 1997;15:1445-50.
15. De Bekker-Grob EW, Polder JJ, Mackenbach JP, Meerding WJ. Towards a comprehensive estimate of national spending on prevention. BMC Public Health. 2007;7:252.
16. Schwappach DL, Boluarte TA, Suhrcke DM. The economics of primary prevention of cardiovascular disease: a systematic review of economic evaluations. Cost Eff Resour Alloc. 2007;5:5-14.
17. Diari Oficial de la Generalidad de Catalunya per la que es regulen els conceptes facturables del Instutut Català de la Salut. No4540-30/12/2005.
18. Riani V, Lima E, López J, Insagaray J, Rodríguez I, Arago A. Valor predictivo positivo de las técnicas de tamizaje en infecciones transmisibles por transfusión. Disponible en: www.hemoterapia.edu.uy/ información/index.php?ClassId=13
19. Hadler SC, Francis DP, Maynard JE, Tohmpson SE, Judson FN, Echenberg FN, et al. Long term immunogenicity and efficacy of hepatitis B vaccine in homosexoual men. N Engl J Med. 1986;315:209-14.
20. Instrucció 1/2006. Criteris d'indicació de tractament de les hepatitis víriques. Direcció General de recursos sanitaris. Departament de Salut. Generalitat de Catalunya.
21. MSC. Datos básicos de la salud y de los servicios sanitarios en España 2003. Evolución de las enfermedades infecciosas de declaración obligatoria. Casos declarados 1999-2003 [consultado 30/04/2007]. Disponible en: www.msc.es/estadEstudios/estadisticas/docs/datos- bancos-salud.pdf
22. Valerio L, Guerrero L, Martínez O, Sabrià M, Garrido P, Fabregat A, et al. Los inmigrantes viajeros. Aten Primaria. 2003;32:330-6.
23. Generalitat de Catalunya. IDESCAT. Estadística bàsica de Catalunya. Residents estrangers per país de nacionalitat [consultado 04/05/2007]. Disponible en: http://www.idescat.net/dequavi/?TC=444&V0= 1&V1=11
24. Ramos JM, Pastor C, Masia MM, Cascales E, Royo G, Gutiérrez-Rodero F. Health in the immigrant population: prevalence of latent tuberculosis, hepatitis B, hepatitis C, human immunodeficiency virus and syphilis infection. Enferm Infect Microbiol Clin. 2003;21:540-2.
25. Gutiérrez M, Tajada P, Álvarez A, de Julián R, Baquero M, Soriano V, et al. Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B anc C viruses among immigrant sex workers in Madrid, Spain. J Med Virol. 2004;74:521-7.
26. Roudot-Thoraval F, Kouadja F, Wirquin V, Thiers V, Avons P, Brechot C, et al. Prevalence of HBs antigen carriers and markers of B virus replication in a population of pregnant women, France. Gastroenterol Clin Biol. 1989;13:353-6.
27. Sola R, Cruz de Castro E, Hombrados M, Planas R, Coll S, Jardí R, et al. Prevalence of hepatitis B and hepatitis C viruses in different countries of Catalonia; Spain: cross-sectional study. Med Clin (Barc). 2002;119:90-5.
28. Echevarría JM, Avellón A, Magnius LO. Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol. 2005;76:176-84.
29. Brown RE, De Cock E, Colin X, Antonanzas F, Iloeje UH. Hepatitis B managementcosts in France, Italy, Spain and the United Kingdom. J Clin Gastroenterol. 2004;38:169-74.
30. Arroyo V, Salleras L, Simón Marco MA, Rodríguez- Frías F, Jardí R, Aguilar J, et al. Consenso para el tratamiento de la hepatitis B y C. Disponible en: http://www.aeeh.org/doc/ConsensoVHB-VHC. pdf
31. Campos RH, López JL. Significación clínica y terapéutica de la heterogeneidad del virus B de la hepatitis. Rev Clin Esp. 2001;713-4.
32. Toro C, Jiménez V, Rodríguez C, del Romero J, Rodés B, Holguín A, et al. Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain. J Med Virol. 2006;78:1599-608.
33. Sánchez-Tapias JM. Natural history of chronic hepatitis B. En: Arroyo, Navasa, Forns, Bataller, Sánchez-Fuego y Rodés, editores. Barcelona: Ars Medica; 2005.
34. Romea-Lecumberri S, Durán-Pla E, Cabezos-Otón J, Bada-Aínsa. Immunologic situation of hepatitis B in immigrants. Strategy for vaccination. Med Clin (Barc). 1997;109:656-60.
35. Banatvala J, Van Damme P, Emiroglu M. Hepatitis B immunization in Britain: time to change?. BMJ. 2006;332:804-5.
36. Lee TA, Veenstra DL, Iloeje UH, Sullivan SD. Cost of chronic hepatitis B infection in the United Status. J Clin Gastroenterol. 2004;38:144-7.
37. Habarth S, Szucs T, Berger K, Jilg W. The economic burden of hepatitis B in Germany. Eur J Epidemiol. 2004;16:173-7.
38. López-Vélez R, Huerga H, Turrientes MC. Infectious diseases in immigrants from the perspectiva of a tropical medicine referal unit. Am J Trop Med Hyg. 2003;69:115-21.
39. Bruguera M, Forns X. Hepatitis C in Spain. Med Clin (Barc). 2006;127:113-7.
40. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. HBV, HCV and HDV infections in Albanian refugees in Southern Italy. Epidemiol Infect. 2000;125:163-7.
41. Ahmad K. Pakistan: a cirrhotic state? Lancet. 2004;364:1843-4.
42. Del Poggio C, Mazzoleni P. Screening in liver diseases. World J Gastroenterol. 2006;5272-80.
43. Josset V, Torre JP, Tavolacci MP, Van Rossen-Magnani V, Anselme K, Merle V, et al. Efficency of hepatitis C virus screening strategies in general practice. Gastroenterol Clin Biol. 2004;28:458-9.